Fischer Medical
http://fischermti.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Fischer Medical
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2009
Medical device financing--primarily made up of late venture rounds--totaled just over $1 billion in Q3 2009, a 19% increase over the previous quarter. Acquisition dollars in the industry also surpassed $1 billion and included two $400 million-deals by Abbott. Most of the third quarter financing into in vitro diagnostics and research/analytical came from Qiagen's $628 million FOPO. And Agilent's $1.5 billion purchase of bioanalytical instrument maker Varian was the highest-value takeover.
Breast Imaging Finds Needles in Haystacks
Digital mammography's real potential is still unknown, though proponents argue it will find more cancers than conventional film screen mammography. Its acceptance could also lead to the development of adjunctive technologies that can differentiate cancerous from benign tissue.
Digital Mammography Comes of Age
Digital mammography is about to become available, but will payers pay more for a technology which isn't yet proven to improve patient outcomes?
TransScan Medical Inc.
Diagnostic Imaging; Breast Cancer. TransScan Medical is developing a new diagnostic modality that it will initially market to radiologists as an adjunct to mammography. The company's technology is based on the electrical impedance properties of tissue.
Company Information
- Industry
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- X-ray
-
Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
-
- Bloom Associates, Ltd.
- Fisher Medical Technologies
- H.G. Fischer Company
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice